Here we provide a selection of scientific publications related to IOZK immunotherapy. You can use the filters to make a selection according to tumor types and methods, or enter search terms.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-09-11 / Mol. Cancer 2013 Sep;12(1):103https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-09-11 / Mol. Cancer 2013 Sep;12(1):1032013-09-11 00:00:002019-02-15 09:22:36Oncolytic viruses as therapeutic cancer vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-09-01 / Colorectal Dis 2013 Sep;15(9):1107-14https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-09-01 / Colorectal Dis 2013 Sep;15(9):1107-142013-09-01 00:00:002019-02-15 08:39:14Phase II study of concomitant chemoradiotherapy with local hyperthermia and metronidazole for locally advanced fixed rectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-08-14 / Cancers (Basel) 2013 Aug;5(3):1020-48https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-08-14 / Cancers (Basel) 2013 Aug;5(3):1020-482013-08-14 00:00:002021-11-15 14:43:30Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-08-13 / Cryobiology 2013 Oct;67(2):235-40https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-08-13 / Cryobiology 2013 Oct;67(2):235-402013-08-13 00:00:002019-02-15 08:45:41Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-08-03 / Arch. Gynecol. Obstet. 2014 Jan;289(1):155-62https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-08-03 / Arch. Gynecol. Obstet. 2014 Jan;289(1):155-622013-08-03 00:00:002019-02-15 08:45:49In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-08-01 / Scand. J. Immunol. 2013 Aug;78(2):167-71https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-08-01 / Scand. J. Immunol. 2013 Aug;78(2):167-712013-08-01 00:00:002019-02-15 08:39:49Current status and future perspectives of dendritic cell-based cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-08-01 / Breast 2013 Aug;22 Suppl 2:S96-9https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-08-01 / Breast 2013 Aug;22 Suppl 2:S96-92013-08-01 00:00:002019-02-15 08:50:01Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-07-13 / Ann. Surg. Oncol. 2013 Oct;20(10):3233-9https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-07-13 / Ann. Surg. Oncol. 2013 Oct;20(10):3233-92013-07-13 00:00:002019-02-15 08:50:02Response to HER-2 pulsed DC1 vaccines is predicted by both HER-2 and estrogen receptor expression in DCIS
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-07-02 / Cancer Immunol. Immunother. 2013 Sep;62(9):1499-509https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-07-02 / Cancer Immunol. Immunother. 2013 Sep;62(9):1499-5092013-07-02 00:00:002019-02-15 08:46:28Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-06-21 / Cancer Treat. Rev. 2013 Dec;39(8):891-907https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-06-21 / Cancer Treat. Rev. 2013 Dec;39(8):891-9072013-06-21 00:00:002019-02-15 08:46:27Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-06-19 / Antioxid. Redox Signal. 2013 Dec;19(17):2141-56https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-06-19 / Antioxid. Redox Signal. 2013 Dec;19(17):2141-562013-06-19 00:00:002013-06-19 00:00:00Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-06-18 / J Transl Med 2013 Jun;11:149https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-06-18 / J Transl Med 2013 Jun;11:1492013-06-18 00:00:002019-02-15 08:52:12A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
Oncolytic viruses as therapeutic cancer vaccines
Phase II study of concomitant chemoradiotherapy with local hyperthermia and metronidazole for locally advanced fixed rectal cancer
Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma
TRAIL is involved in the tumoricidal activity of mouse natural killer cells stimulated by Newcastle disease virus in vitro
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer
In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer
Heat-shock proteins as dendritic cell-targeting vaccines–getting warmer
Current status and future perspectives of dendritic cell-based cancer immunotherapy
Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium
Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer
Response to HER-2 pulsed DC1 vaccines is predicted by both HER-2 and estrogen receptor expression in DCIS
A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
Melanoma immunotherapy using mature DCs expressing the constitutive proteasome
Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy
Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme
Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer